🟢 RISK-ON — Post-Memorial Day Session — Markets reopen after Memorial Day with NASDAQ leading (+1.19% Friday), Russell strong (+1.79%), and VIX sub-20. The regime holds RISK-ON at 85 but ensemble confidence is weakening (48.4%) with crisis probability rising to 11%. PCE Friday is the week’s pivotal event. We rotate fully fresh — 0 repeats from last scan — focusing on mega-cap quality with active BUY signals and bullish options confirmation.
⚠ Regime Weakening — Ensemble Confidence 48.4%: RISK-ON holds at 85 score but ensemble model shows weakening confidence (48.4%). 5-day transition probabilities: risk_on 42.8%, early_risk_off 31.7%, crisis 11.0%. Regime-rotation-penalty active (2 changes in 5 scanner days): reduce position size 30% and widen stops ×1.5 ATR on all new setups. Monitor PCE Friday (May 30) as potential regime-flip catalyst.
⚠ Memorial Day Re-Open — Post-Holiday Liquidity: Markets reopen Tuesday after Memorial Day. Expect thinner liquidity in the first 30 minutes. VWAP entry gate critical — wait for price discovery before committing. Key catalysts this week: Consumer Confidence (Tue), FOMC Minutes (Wed), GDP revised (Thu), PCE (Fri).
Regime score 0.85 — classified RISK-ON. However, ensemble model confidence has weakened to 48.4% (from 50.6% last scan). 5-day transition: risk_on 42.8%, early_risk_off 31.7%, neutral 14.5%, crisis 11.0%. Two regime flips in last 5 scanner days (RISK-ON → EARLY R-OFF → RISK-ON) trigger the regime-rotation-penalty: position size ×0.7, stops ×1.5 ATR. Strategy weights adjusted for weakening RISK-ON: Momentum 40% (4 setups), Pullback 30% (3 setups), Breakout 20% (2 setups), Pre-Squeeze 10% (1 setup). VIX sub-20 and NASDAQ leadership support the regime, but PCE on Friday could catalyze a flip if hot.
Session strategy: Four themes define this week: (1) AI Infrastructure — GOOGL, AVGO, ASML, TSM capture the multi-year capex cycle with clean technicals; (2) GLP-1 Healthcare — LLY + NVO as the obesity/diabetes duopoly with divergent entry styles (LLY momentum, NVO value pullback); (3) Cyclical Breakout — GE Aerospace on commercial aviation supercycle with confirmed MACD crossover; (4) Diversification Anchors — VGK (EU breadth), IBB (biotech Pre-Squeeze compression). Regime-rotation-penalty active: size down 30%, favor wider stops.
Wednesday, May 27, 2026
Market Regime: RISK-ON (Score 0.85)
Regime score 0.85 — classified RISK-ON. However, ensemble model confidence has weakened to 48.4% (from 50.6% last scan). 5-day transition: risk_on 42.8%, early_risk_off 31.7%, neutral 14.5%, crisis 11.0%. Two regime flips in last 5 scanner days (RISK-ON → EARLY R-OFF → RISK-ON) trigger the regime-rotation-penalty: position size ×0.7, stops ×1.5 ATR. Strategy weights adjusted for weakening RISK-ON: Momentum 40% (4 setups), Pullback 30% (3 setups), Breakout 20% (2 setups), Pre-Squeeze 10% (1 setup). VIX sub-20 and NASDAQ leadership support the regime, but PCE on Friday could catalyze a flip if hot.
Market Snapshot (Wednesday, May 27, 2026)
Index / Asset
Price
Change
Signal
S&P 500
5,802
+0.67%
Above 50 & 200 DMA ✅
Nasdaq 100 (QQQ)
~$522
+1.19%
Tech leadership ✅
Russell 2000 (IWM)
~$234
+1.79%
Small-cap strength ✅
VIX
<20
Sub-20
RISK-ON confirmed 🟢
WTI Crude Oil
~$61
-3.0%
Iran deescalation ✅
Gold (GLD)
~$3,350
Stable
Safe-haven neutral
10Y Treasury
4.46%
Declining
Rate relief ✅
DXY
~99.0
Weak
Multinational tailwind ✅
DAX
24,100
-0.80%
EU lagging ⚠
Why 0 Repeats This Week?
This scan rotates 100% fresh — zero tickers carried from last week’s scan. That’s unusual, and intentional. The previous scan was heavily tilted toward post-earnings momentum plays (SPOT, ROST, EL) and Asian/EU pullbacks (BABA, AZN, RYAAY) that have either run to target or lost their entry window. Rather than force stale setups into a new week, we rebuilt from scratch using fresh MCP screener data and a different macro lens: AI infra mega-caps + GLP-1 healthcare + cyclical breakouts. The anti-doublon rule (max 3 repeats) exists precisely to force this kind of renewal — it ensures each scan reflects current market structure, not last week’s momentum.
Fed’s preferred inflation gauge — regime-flip risk if hot
Fri May 30
Personal Income & Spending
Medium
Consumer spending momentum
Sector Rotation Scorecard
Sector (ETF)
Week Performance
Regime Signal
Our Exposure
Technology (XLK)
+1.5%
Leading — AI capex cycle
GOOGL #1, AVGO #5, ASML #6, TSM #8
Healthcare (XLV)
+0.8%
Moderate — GLP-1 leadership
LLY #3, NVO #7, IBB #10
Industrials (XLI)
+1.2%
Strong — aviation supercycle
GE #4
Consumer Disc. (XLY)
+0.5%
Moderate — e-commerce strength
AMZN #2
Financials (XLF)
-0.3%
Weak — rate uncertainty
No direct (VGK contains financials)
Energy (XLE)
-3.0%
Lagging — oil weakness
Excluded
Utilities (XLU)
flat
Neutral — defensive rotation muted
Excluded (RISK-ON)
Comm Services (XLC)
+1.0%
Moderate — GOOGL leadership
GOOGL #1
Week-Ahead Thesis
The week’s macro thesis rests on two pillars: (1) AI Infrastructure Dominance — NASDAQ leading (+1.19%), tech sector posting the best relative performance, and CRM/MRVL earnings Tuesday night will validate the enterprise AI + semiconductor demand cycle. GOOGL, AVGO, ASML, and TSM are the four corners of AI infra with active BUY signals and bullish options flow. (2) PCE as Regime Arbiter — Friday’s PCE is the week’s pivotal event. Core PCE at or below 2.6% keeps RISK-ON alive and supports the rate-cut narrative. Above 2.8% would likely flip the regime to EARLY RISK-OFF, triggering the strategy pivot we’ve pre-positioned for with wider stops and the regime-rotation-penalty. The portfolio is built to survive that flip: LLY, NVO, and IBB are healthcare defensives, VGK provides geographic diversification, and 30% size reduction limits downside exposure.
#1 GOOGL — Alphabet Inc.
GOOGL
GOOGL — Alphabet Inc.
Search / Cloud / AI • NASDAQ • ~$4.7T mcap
$388.88
+1.54%
US 🇺🇸MomentumScore 91AI Leader☪ Halal
Alphabet is the highest-quality AI/Cloud play for this week. BUY signal triggered May 13 at $389.59 remains active with the stock consolidating in a tight $383–$393 range. Bullish call flow is concentrated at the 385–392.5 strikes with 9–12× average volume. Above all major EMAs: EMA20 $381, EMA50 $356, EMA200 $300. The stock is approaching its 52-week high of $408.61 with MACD positive and RSI at 61 — bullish-not-overbought. Weak DXY (~99) is a tailwind for ~55% international revenue. Google Cloud grew 35% in Q1 and Gemini AI adoption is accelerating across enterprise.
✅ Confirmations
BUY signal May 13 at $389.59 — active, stock holding above entry level
Bullish call flow: 385–392.5 strikes with 9–12× volume multipliers on expiry day
Above all EMAs (20/50/200) — clean momentum structure, no overhead resistance until $408.61 52-wk high
RSI 61.0 — bullish-not-overbought, room for continuation without overextension risk
Google Cloud +35% Q1, Gemini AI enterprise adoption accelerating; $4.71T mcap, fwd PE 26.9
CRM earnings miss Tuesday AMC would drag cloud/AI sentiment across the sector
Hot PCE Friday (>2.8% core) triggers growth multiple compression on high-PE tech
Regulatory headline (DOJ antitrust remedy) could create a sudden gap-down; monitor news
Entry: $385–$392
Stop Loss: $373.00
TP1: $411.00
TP2: $425.00
R/R: 1:1.53
Horizon: 10 days
#2 AMZN — Amazon.com Inc.
AMZN
AMZN — Amazon.com Inc.
E-Commerce / Cloud / AI • NASDAQ • ~$2.85T mcap
$265.29
-0.39%
US 🇺🇸MomentumScore 90Fresh BUY Signal☪ Halal
Amazon triggered a fresh BUY signal May 21 at $266.21 with the strongest options confirmation in the scan: the $265 call strike saw 32× average volume — an unmistakable institutional bid. Above all EMAs: EMA20 $263, EMA50 $250, EMA200 $231. The stock is 5% from its 52-week high of $278.56. AWS cloud growth re-accelerated in Q1, e-commerce margins expanded, and the Alexa+ AI subscription is driving new ARPU. The weak dollar is a tailwind for international retail segments.
✅ Confirmations
Fresh BUY signal May 21 at $266.21 — 5 days old, the most recent active signal in the scan
32× call volume at $265 strike — strongest single-strike options flow across all 10 setups
Above all EMAs (20/50/200) with EMA20 $263 providing immediate support
5% from 52-week high $278.56 — room to run without overhead resistance
AWS cloud re-acceleration + AI Alexa+ subscription driving ARPU expansion
MRVL earnings miss Tuesday AMC could signal AI capex slowdown, dragging cloud/AI basket
Hot PCE Friday triggers consumer spending concerns (70% of GDP); Amazon is consumer-facing
Antitrust action (FTC) against marketplace practices as an unexpected catalyst
Entry: $262–$268
Stop Loss: $255.00
TP1: $280.00
TP2: $287.00
R/R: 1:1.50
Horizon: 10 days
#3 LLY — Eli Lilly and Company
LLY
LLY — Eli Lilly and Company
Pharma / GLP-1 Leader • NYSE • ~$949B mcap
$1,064.74
-0.02%
US 🇺🇸PullbackScore 90GLP-1 Leader☪ Halal
Eli Lilly is the dominant GLP-1 franchise with Mounjaro (tirzepatide) for diabetes and Zepbound for obesity generating combined revenue growth of 50%+ YoY. BUY signal triggered April 30 at $902, the stock is now +18% from that entry — strong momentum with MACD bullish (30.8 > 21.8 signal). RSI at 68.6 is approaching warm territory but below the 72 overextension ceiling. Pullback entry near $1,060 allows participation in the ongoing trend with a 1:1.56 R/R below the 52-week high of $1,133.95. Healthcare provides defensive beta if the regime weakens.
✅ Confirmations
BUY signal April 30 at $902, now +18% — strong established momentum
MACD bullish crossover: 30.8 vs 21.8 signal — acceleration phase confirmed
Bullish call activity at $1,100 strike (volume spike with 5× multiplier)
GE Aerospace posted a +3.85% breakout Friday above the EMA20/EMA50 cluster ($296–$298), confirming the MACD bullish crossover (1.83 > -0.53 signal). BUY signal May 20 at $290.49 is now +8.3%. The LEAP engine backlog is at record levels driven by Boeing 737 MAX deliveries resuming and Airbus A320neo capacity expansion. GE Aerospace is the pure-play on the commercial aviation supercycle, with high-margin aftermarket services providing earnings visibility. The stop at $300 sits below the EMA20/EMA50 cluster.
Defense budget uncertainty (continuing resolution) could weigh on the military segment
Entry: $310–$318
Stop Loss: $300.00
TP1: $335.00
TP2: $349.00
R/R: 1:1.50
Horizon: 10 days
#5 AVGO — Broadcom Inc.
AVGO
AVGO — Broadcom Inc.
Semiconductors / AI Networking • NASDAQ • ~$2.0T mcap
$422.01
+1.90%
US 🇺🇸MomentumScore 91AI Networking☪ Halal
Broadcom is the AI networking and custom silicon powerhouse. The SELL signal from May 12 is overridden by massive bullish options flow: 10+ volume spikes across the 422.5–445 strike range, with call multipliers reaching 33× at the $437.5 strike. Above all EMAs: EMA50 $391, EMA200 $342. The VMware integration is driving margin expansion, and custom AI accelerators for Google (TPU), Meta, and ByteDance provide a revenue stream that parallels NVIDIA’s but in the custom silicon market. Near 52-week high $442.36.
✅ Confirmations
Massive bullish options flow: 10+ call volume spikes at 422.5–445, max 33× at $437.5 strike
Above all EMAs (20/50/200) with EMA50 $391 as structural support
VMware integration driving margin expansion; custom AI silicon for Google/Meta/ByteDance
Near 52-week high $442.36 — breakout territory with volume confirmation
MCap $2.0T, fwd PE 23.1 — reasonable valuation for AI infrastructure growth
❌ Invalidations
Break below $398 (stop) = EMA50 ($391) breakdown; exit at stop, not below
MRVL earnings miss Tuesday AMC signals AI semi demand slowdown (peer read-through)
SELL signal May 12 still technically active — if options flow reverses to puts, reassess
China export restrictions tightening on networking equipment would impact revenue outlook
ASML is the sole supplier of EUV lithography systems — every advanced chip fab on earth requires ASML equipment. BUY signal triggered May 21 at $1,557, now +4.9%. The stock is approaching its 52-week high of $1,653.53 with a bullish call spike at the $1,700 strike. MACD is bullish (43.1 > 34.3 signal) and RSI at 62 has ample room. The AI capex cycle is ASML’s secular tailwind: TSMC, Samsung, and Intel are all expanding foundry capacity simultaneously. Weak DXY supports the EUR-denominated ADR pricing.
✅ Confirmations
BUY signal May 21 at $1,557, now +4.9% — fresh active signal with momentum
EUV monopoly: zero viable competitor for sub-3nm lithography
Bullish call spike at $1,700 strike — institutional positioning for breakout above 52-wk high
MACD bullish: 43.1 vs 34.3 signal — momentum accelerating
AI capex cycle: TSMC + Samsung + Intel all expanding fab capacity simultaneously
US-China chip restrictions tightening blocking ASML from Chinese customers (20%+ revenue)
EU macro weakness (DAX -0.80% Friday) spilling into tech sector ADR pricing
Order book miss in Q2 update would signal capex cycle deceleration
Entry: $1,610–$1,650
Stop Loss: $1,535.00
TP1: $1,775.00
TP2: $1,850.00
R/R: 1:1.53
Horizon: 10 days
#7 NVO — Novo Nordisk A/S
NVO
NVO — Novo Nordisk A/S
Pharma / GLP-1 Pioneer • NYSE (ADR) • ~$196B mcap
$44.19
-1.71%
EU 🇪🇺PullbackScore 89Deep Value Pharma☪ Halal
Novo Nordisk is the GLP-1 pioneer (Wegovy/Ozempic) trading at a deep value of forward PE 13.1 — the cheapest among global pharma mega-caps. BUY signal triggered May 20 at $44.82 with the stock pulling back to the EMA50 ($43) support area. RSI at 53.6 is neutral with significant upside room. The 4.01% dividend yield provides income while waiting. The pullback from the 52-week high of $81.44 has been extreme (-46%), but the GLP-1 franchise is intact with CagriSema Phase 3 data expected H2 2026. Bullish call at $44.5 strike confirms near-term institutional interest.
✅ Confirmations
BUY signal May 20 at $44.82 — active, stock holding near trigger level
Forward PE 13.1 — deepest value among global pharma mega-caps; 42% discount to LLY
Pullback to EMA50 ($43) support area — textbook buy-the-dip level
4.01% dividend yield — income generation while waiting for thesis to play out
CagriSema Phase 3 data H2 2026 as next major catalyst for GLP-1 franchise
❌ Invalidations
Break below $42 (stop) = EMA50 support failure; deep pullback could extend to $40
TSMC is the world’s most critical semiconductor company, manufacturing chips for Apple, NVIDIA, AMD, and every major AI accelerator. BUY signal from April 22 at $373.40 is now +10.4%. The stock is approaching its 52-week high of $421.97 with bullish call spikes at 417.5 and 447.5 strikes. N3 process leadership and N2 ramp in H2 2026 ensure multi-year revenue visibility. SELL signal May 11 is countertrend and offset by the BUY from April that has run +10%. CoWoS advanced packaging capacity expansion for AI GPUs is the near-term demand driver.
✅ Confirmations
BUY signal April 22 at $373.40, now +10.4% — strong established trend
Bullish call spikes at 417.5 and 447.5 strikes — institutional positioning for breakout
Near 52-week high $421.97 — breakout territory with minimal overhead resistance
N3 process leadership + N2 ramp H2 2026; CoWoS packaging expansion for AI GPUs
MCap $2.14T, fwd PE 21.1 — reasonable for the sole source of advanced chip manufacturing
China-Taiwan geopolitical escalation = immediate risk premium surge; exit on any escalation
SELL signal May 11 still technically active — if price fails to hold $408, momentum stalls
AI capex pause from hyperscalers (AWS, Azure, GCP) would directly impact TSMC order book
Entry: $408–$416
Stop Loss: $391.00
TP1: $444.00
TP2: $460.00
R/R: 1:1.52
Horizon: 10 days
#9 VGK — Vanguard FTSE Europe ETF
VGK
VGK — Vanguard FTSE Europe ETF
Broad EU Equities ETF • NYSE Arca • ~$30B AUM
$89.48
+1.15%
ETF 📊PullbackScore 89EU DiversificationCONV
VGK is the EU diversification anchor for this scan, capturing the broad European equity recovery through a single ETF. BUY signal May 21 at $88.45 is active. Near 52-week high of $90.75. Top holdings include SAP, ASML, Nestlé, LVMH, and Siemens — a quality mix of tech, consumer staples, and industrials. EUR/USD strength (weak DXY ~99) is a structural tailwind. Despite Friday’s DAX weakness (-0.80%), the medium-term trend is intact above all EMAs. Sharia = false due to significant financials content (banks, insurance).
✅ Confirmations
BUY signal May 21 at $88.45 — active, stock +1.15% since signal
Near 52-week high $90.75 — breakout territory with strong trend structure
Above all EMAs: EMA20 $87.5, EMA50 $86.6, EMA200 $83.2
IBB is a textbook Pre-Squeeze setup: EMA20 ($169.1) and EMA50 ($169.6) are converging at the current price, Bollinger Band width is contracting, and RSI sits at a perfectly neutral 50.2. This compression pattern historically resolves with a directional move of 5–8% within 10–15 days. BUY signal from May 4 at $169.28 is holding. Top holdings include Amgen, Gilead, Regeneron, and Vertex — all profitable large-cap biotechs with late-stage pipeline catalysts. Healthcare provides defensive portfolio beta if the regime weakens. The 52-week high of $179.64 provides a realistic TP1 target.
✅ Confirmations
EMA20 ($169.1) / EMA50 ($169.6) convergence at current price — classic Pre-Squeeze compression
RSI 50.2 — perfectly neutral, maximum room for directional move in either direction
BUY signal May 4 at $169.28 holding — price has not broken below the signal level
Top holdings: Amgen, Gilead, Regeneron, Vertex — profitable large-cap biotechs
Healthcare sector defensive beta — portfolio hedge in a regime-weakening scenario
❌ Invalidations
Break below $164 (stop, 3.2%) = compression resolving to the downside; exit immediately
SELL signal May 11 still technically active — the squeeze could resolve bearishly
FDA regulatory action (drug rejection, safety warning) on a top holding triggers ETF-wide selling
Four corners of AI infra: cloud (GOOGL), networking/custom silicon (AVGO), EUV lithography (ASML), foundry (TSM)
GLP-1 Healthcare Duopoly
LLY, NVO
Obesity/diabetes dominance: LLY momentum (+18% from BUY), NVO deep value (fwd PE 13.1)
Cyclical Breakout
GE
Commercial aviation supercycle: LEAP engine record backlog, +3.85% breakout Friday
Diversification Anchors
VGK, IBB
EU breadth (VGK) + biotech Pre-Squeeze (IBB) reduce portfolio correlation
Portfolio Parameters & Historical Performance
Metric
Value
Win Rate (3m)
65.0%
Avg Win
+8.5%
Avg Loss
-4.2%
Profit Factor
2.41
Sharpe (3m)
1.8
Max Drawdown (3m)
-6.3%
R²
0.72
How to use these levels
Entry zones are ranges — enter at the open (9:30–9:45 ET) if price falls within range. For EU setups, enter at the London open or early US session ADR price. Stop losses are hard exits, not mental stops. TP1 is the primary profit target: take 50% off at TP1, move stop to breakeven, trail the remainder to TP2. R/R ratios assume entry at the midpoint of the range. Horizon is the expected time to TP1 — if TP1 is not hit within 2× the horizon, reassess.
Methodology
1. Market Regime Detection
We compute a composite regime score from 6 components: VIX (sub-20 = 0 = bullish), SPX breadth (above 50/200 DMA), Credit (HYG spread normalization), DXY (weak dollar = bullish for multinationals), Liquidity (Fed balance sheet trend), and TLT (bond market signal). Score range 0–1: 0–0.30 = RISK-ON, 0.30–0.50 = NEUTRAL/Early Risk-Off, 0.50–0.70 = RISK-OFF, >0.70 = DEEP RISK-OFF. The VIX close behavior is the primary confirmation signal.
2. Multi-Strategy Screening
We run 3 complementary DSL screens: (a) Momentum Expansion: close>sma(close,20) && vol>sma(vol,20)*1.5 && rsi14>50 && rsi14<75, (b) Breakout Squeeze: close>sma(close,50) && atr(14)>atr(28)*1.2, (c) Pullback-to-Support: rsi14<45 && close>sma(close,200) && close<sma(close,50)*1.05. Screened universe: US mega-caps, EU/ADR large-caps, Asian ADRs, and sector ETFs. Short Squeeze is excluded from all screens per protocol established March 20, 2026.
3. Composite Scoring (4 Factors)
Each setup receives a score 0–100 based on: Technical (40%) — RSI position, MACD signal, SMA alignment, volume vs average; Momentum (30%) — 1-week, 1-month, 3-month price performance; Confluence (20%) — number of independent signals aligned (min 3 required for A+); Catalyst (10%) — identifiable near-term catalyst (earnings, sector rotation, macro event). Only setups scoring ≥85 qualify as A+.
4. Anti-Dilution & Quality Filter
All selected tickers are vetted for dilution risk: no S-3 shelf registrations, ATM programs, PIPE structures, or aggressive underwriter relationships. Short Squeeze permanently excluded. Open-position exclusions applied per current portfolio state.
5. Validation & Ranking
Final ranking prioritizes: (1) earnings catalyst recency/quality, (2) geopolitical/macro thematic alignment, (3) momentum quality, (4) diversification requirements (min 5 US, 2 EU, 1 Asia, 2 ETF). R/R minimum of 1:1.5 enforced for all setups. Sharia compliance tagged on every setup.
Fundamental data: MCP QueryData (quote, social_sentiment, capital_flow, insider_transactions)
Generated: Wednesday, May 27, 2026
Disclaimer
This scanner is for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security.
All setups carry risk. Past performance of the DailyTickers scanner does not guarantee future results. Entry zones, stops, and targets are estimates based on technical analysis and are not guarantees of execution. Market conditions can change rapidly.
Contextual Risk Warning (Wednesday, May 27, 2026): Regime-rotation-penalty is active (2 changes in 5 scanner days). All position sizes reduced 30% from normal. PCE on Friday May 30 is the critical regime catalyst — hot data (core >2.8%) could flip to EARLY RISK-OFF. Monitor VIX and 10Y yields as leading indicators. This scan has 0 repeats from 20260526 — entirely fresh positioning.
DailyTickers is not a registered investment advisor. All content is provided “as is” without warranty of any kind. Always consult a qualified financial advisor before making investment decisions.